Faes Farma SA
FFEA
Company Profile
Business description
Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.
Contact
Maximo Aguirre, 14
Leioa
Vizcaya48940
ESPT: +34 901120362
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,761
Stocks News & Analysis
stocks
Unconventional wisdom: A controversial income pick
Rigid definitions of income and growth shares may be holding investors back.
stocks
How to avoid dividend disaster
Thinking about common reasons a company might stop paying a dividend can help income investors avoid disappointment.
stocks
Why ASX miners will handily beat banks in the long-term
After a stellar run for banks, investors are wondering whether they can continue their outperformance or if a rotation into miners is imminent. There’s a good case that a switch is coming, and it may last decades, not just years.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,780.30 | 4.80 | -0.05% |
CAC 40 | 7,973.03 | 34.59 | -0.43% |
DAX 40 | 21,787.00 | 115.42 | -0.53% |
Dow JONES (US) | 44,303.40 | 444.23 | -0.99% |
FTSE 100 | 8,700.53 | 26.75 | -0.31% |
HKSE | 21,133.54 | 241.92 | 1.16% |
NASDAQ | 19,523.40 | 268.59 | -1.36% |
Nikkei 225 | 38,787.02 | 279.51 | -0.72% |
NZX 50 Index | 12,902.19 | 57.60 | 0.45% |
S&P 500 | 6,025.99 | 57.58 | -0.95% |
S&P/ASX 200 | 8,511.40 | 9.30 | -0.11% |
SSE Composite Index | 3,303.67 | 33.01 | 1.01% |